HENNION & WALSH ASSET MANAGEMENT, INC. Krystal Biotech, Inc. Transaction History

HENNION & WALSH ASSET MANAGEMENT, INC. portfolio value:

$2.83M
portfolio value

HENNION & WALSH ASSET MANAGEMENT, INC. quarter portfolio value change:

+6.15%
quarter

Krystal Biotech, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +23.23% 7.66K shares 668K $69.7 40.65K
Q2 2022 share Increase +41.19% 9.62K shares 611K $65.66 32.99K
Q1 2022 share Increase +65.30% 9.23K shares 566K $66.54 23.36K
Q4 2021 share Increase 0.00% 14.13K shares 989K $70.5 14.13K